Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review

Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2021;17(2):109–18.

PubMed  Article  Google Scholar 

van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.

PubMed  Article  Google Scholar 

Carron P, Van Praet L, Jacques P, Elewaut D, Van den Bosch F. Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin). Rheum Dis Clin N Am. 2012;38(3):583–600.

Article  Google Scholar 

Biggioggero M, Crotti C, Becciolini A, Miserocchi E, Favalli EG. The management of acute anterior uveitis complicating spondyloarthritis: present and future. Biomed Res Int. 2018;2018:9460187.

PubMed  PubMed Central  Article  Google Scholar 

Martin TM, Smith JR, Rosenbaum JT. Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr Opin Rheumatol. 2002;14(4):337–41.

PubMed  Article  Google Scholar 

Bacchiega ABS, Balbi GGM, Ochtrop MLG, de Andrade FA, Levy RA, Baraliakos X. Ocular involvement in patients with spondyloarthritis. Rheumatology (Oxford). 2017;56(12):2060–7.

CAS  Article  Google Scholar 

Gutteridge IF, Hall AJ. Acute anterior uveitis in primary care. Clin Exp Optom. 2007;90(2):70–82.

PubMed  Article  Google Scholar 

O’Rourke M, Haroon M, Alfarasy S, Ramasamy P, FitzGerald O, Murphy CC. The effect of anterior uveitis and previously undiagnosed spondyloarthritis: results from the DUET cohort. J Rheumatol. 2017;44(9):1347–54.

PubMed  Article  Google Scholar 

Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285–99.

Article  Google Scholar 

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–91.

PubMed  Article  Google Scholar 

Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis. 2006;65(12):1631–4.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52(8):2447–51.

CAS  PubMed  Article  Google Scholar 

Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d’Elia H, Askling J, et al. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis. 2017;76(9):1515–21.

CAS  PubMed  Article  Google Scholar 

Calvo-Río V, Blanco R, Santos-Gómez M, Rubio-Romero E, Cordero-Coma M, Gallego-Flores A, et al. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients. Semin Arthritis Rheum. 2016;46(1):95–101.

PubMed  Article  Google Scholar 

van Denderen JC, Visman IM, Nurmohamed MT, Suttorp-Schulten MS, van der Horst-Bruinsma IE. Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis. J Rheumatol. 2014;41(9):1843–8.

PubMed  Article  Google Scholar 

van Bentum RE, Heslinga SC, Nurmohamed MT, Gerards AH, Griep EN, Koehorst C, et al. Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab—the GO-EASY study. J Rheumatol. 2019;46(2):153–9.

PubMed  Article  Google Scholar 

Rudwaleit M, Rødevand E, Holck P, Vanhoof J, Kron M, Kary S, et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis. 2009;68(5):696–701.

CAS  PubMed  Article  Google Scholar 

Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d’Elia H, et al. Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis. 2021;80(11):1445–52.

PubMed  Article  Google Scholar 

Landewé R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study. Ann Rheum Dis. 2014;73(1):39–47.

PubMed  Article  Google Scholar 

CIMZIA (certolizumab pegol). Product information. Smyrna: UCB Inc; 2019.

Google Scholar 

Rudwaleit M, Rosenbaum JT, Landewé R, Marzo-Ortega H, Sieper J, van der Heijde D, et al. Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis. Arthritis Care Res (Hoboken). 2016;68(6):838–44.

CAS  Article  Google Scholar 

Landewé RB, van der Heijde D, Dougados M, Baraliakos X, Van den Bosch FE, Gaffney K, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann Rheum Dis. 2020;79(7):920–8.

PubMed  Article  Google Scholar 

Landewé R, van der Heijde D, Dougados M, Baraliakos X, Van den Bosch F, Gaffney K, et al. Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment: 48-week outcomes from C-OPTIMISE. Rheumatol Ther. 2020;7(3):581–99.

PubMed  PubMed Central  Article  Google Scholar 

van der Horst-Bruinsma I, van Bentum R, Verbraak FD, Rath T, Rosenbaum JT, Misterska-Skora M, et al. The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW. RMD Open. 2020;6(1):e001161.

PubMed  PubMed Central  Article  Google Scholar 

van der Horst-Bruinsma IE, van Bentum RE, Verbraak FD, Deodhar A, Rath T, Hoepken B, et al. Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study. Ther Adv Musculoskelet Dis. 2021;13:1759720x211003803.

PubMed  PubMed Central  Google Scholar 

van der Heijde D, Dougados M, Landewé R, Sieper J, Maksymowych WP, Rudwaleit M, et al. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford). 2017;56(9):1498–509.

Article  Google Scholar 

Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, et al. A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71(7):1101–11.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rademacher J, Poddubnyy D, Pleyer U. Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720x20951733.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rosenbaum JT, Smith JR. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S143–5.

CAS  PubMed  Google Scholar 

Frantz C, Portier A, Etcheto A, Monnet D, Brezin A, Roure F, et al. Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients. Clin Exp Rheumatol. 2019;37(1):26–31.

PubMed  Google Scholar 

de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.

PubMed  PubMed Central  Article  Google Scholar 

Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955–9.

CAS  PubMed  Article  Google Scholar 

Wright GC, Kaine J, Deodhar A. Understanding differences between men and women with axial spondyloarthritis. Semin Arthritis Rheum. 2020;50(4):687–94.

PubMed  Article  Google Scholar 

Hernández M, Mesquida M, Llorens V, Maza MSDL, Blanco R, Calvo V, et al. THU0381 certolizumab pegol is effective in uveitis associated to spondyloarthritis refractory to other tumour necrosis factor inhibitors. Ann Rheum Dis. 2017;76(Suppl 2):350.

Google Scholar 

Llorenç V, Mesquida M, Sainz-de-la-Maza M, Blanco R, Calvo V, Maíz O, et al. Certolizumab pegol, a new anti-TNF-α in the armamentarium against ocular inflammation. Ocul Immunol Inflamm. 2016;24(2):167–72.

PubMed  Google Scholar 

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, et al. Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis. Clin Exp Rheumatol. 2019;37(2):301–5.

PubMed  Google Scholar 

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, et al. Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. Clin Exp Rheumatol. 2019;37(4):680–3.

PubMed  Google Scholar 

Prieto-Peña D, Calderón-Goercke M, Adán A, Chamorro-López L, Maíz-Alonso O, De Dios-Jiménez Aberásturi JR, et al. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy. Clin Exp Rheumatol. 2021;39(1):105–14.

PubMed  Article  Google Scholar 

Martín-Varillas JCRV, Sanchez-Bilbao L, Gonzalez-Mazon I, Torre I, García Martos A, Sánchez Andrade A, García Aparicio A, De Dios J, Urriticoechea A, Maiz Alonso O, Veroz R, García Valle A, Rodriguez Montero S, Miguelez R, Jovani V, Hernandez Garfella M, Conesa A, Martinez Gonzalez O, Rubio Muñoz P, Peña Sainz-Pardo E, González-Gay M, Blanco R. Treatment with certolizumab pegol in refractory uveitis secondary to immune-mediated inflammatory diseases multicenter study of 39 patients [abstract]. Arthritis Rheumatol. 2020;79:384–5.

Google Scholar 

Robinson PC, Claushuis TA, Cortes A, Martin TM, Evans DM, Leo P, et al. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol. 2015;67(1):140–51.

留言 (0)

沒有登入
gif